Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma |
Stanford University / Julien Sage, PhD |
Innovation Grants |
2018 |
California |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2010 |
California |
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias |
University of California at Santa Cruz / Camilla Forsberg, PhD |
Innovation Grants |
2013 |
California |
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma |
University of California at Santa Cruz / David Haussler, PhD |
Innovation Grants |
2015 |
California |
Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma |
University of California San Francisco / Zulekha Qadeer, PhD |
Young Investigator Grants |
2019 |
California |